AARON SINGH: Open Payments
NPI 1255657060 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 135 payments from 19 companies in 2025. Trend: 2023 $161 · 2024 $271 · 2025 $2,083
Food & beverage: $2,083
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $409 |
| ABBVIE INC. | 26 | $242 |
| AstraZeneca Pharmaceuticals LP | 12 | $214 |
| Novo Nordisk Inc | 12 | $168 |
| Lilly USA, LLC | 12 | $162 |
| Viatris Specialty LLC | 11 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $140 |
| Sumitomo Pharma America, Inc. | 9 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
Products named: REXULTI, UBRELVY, YUPELRI, CAPLYTA, GEMTESA, XIFAXAN, MOUNJARO, BREZTRI.
Industry payments across AR — which companies pay providers there.
